Damora Therapeutics (DMRA) Assets Average (2020 - 2026)

Damora Therapeutics (DMRA) has 7 years of Assets Average data on file, last reported at $398.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 2349.36% year-over-year to $398.0 million; the trailing twelve-month figure through Mar 2026 stood at $398.0 million (up 2349.36% YoY), and the FY2025 full-year result was $138.8 million, up 401.56% from the prior year.
• Assets Average for Q1 2026 stood at $398.0 million, up from $135.6 million in the prior quarter.
• Across five years, Assets Average topped out at $398.0 million in Q1 2026 and bottomed at $12.2 million in Q3 2025.
• The 5-year median for Assets Average is $54.4 million (2023), against an average of $76.4 million.
• The widest annual swing landed in 2024, when Assets Average slumped 54.11%; it then jumped 2349.36% in 2026.
• A 5-year view of Assets Average shows it stood at $77.6 million in 2022, then plunged by 43.13% to $44.1 million in 2023, then tumbled by 54.11% to $20.3 million in 2024, then soared by 569.65% to $135.6 million in 2025, then soared by 193.43% to $398.0 million in 2026.
• The last three Assets Average figures came in at $398.0 million (Q1 2026), $135.6 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.

Peer Comparison